Ventures
Browse a selection of current and former i-lab ventures.
-
All
42
-
Harvard Business School
16
-
Harvard College
7
-
Harvard Faculty of Arts and Sciences
1
-
Harvard John A. Paulson School of Engineering and Applied Sciences
3
-
Harvard Kennedy School
1
-
Harvard Kenneth C. Griffin Graduate School of Arts and Sciences
6
-
Harvard Medical School
21
-
Harvard T.H. Chan School of Public Health
3
-
Harvard University
2
-
Non-Harvard Affiliate
3
-
All
177
-
Aerospace and Defense
4
-
Agriculture
7
-
Aid and Relief
1
-
Architecture, Construction, and Engineering
3
-
Arts and Culture
2
-
Biotech and Therapeutics
16
-
Business Services
3
-
Childhood Development
1
-
Climate and Sustainability
10
-
Consumer Products and Packaged Goods
6
-
Digital Health
16
-
Diversity,
Equity, Inclusion, and Belonging
1
-
Diversity, Equity, Inclusion, and Belonging
1
-
Ecommerce
5
-
Education and Learning
2
-
Education Technology
5
-
Electronics and Hardware
3
-
Employment, Recruiting, and Workforce Development
3
-
Energy, Oil, and Renewables
7
-
Fashion, Beauty, and Retail
3
-
Finance and Insurance
5
-
Fitness and Sports
2
-
Food and Beverages
7
-
Gaming
1
-
Government and Civic Engagement
3
-
Healthcare Delivery
9
-
Hospitality and Tourism
1
-
International Development
1
-
Media and Entertainment
2
-
Medical Devices and Hardware
5
-
Mental Health
1
-
Mentorship and youth development
1
-
Personal Health, Wellness, and Sports
2
-
Real Estate and Housing
3
-
Software/App
12
-
Transportation and Logistics
4
-
AbscoTx
AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
![Absco team]()
-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
![Aperture Bio team]()
-
Celsius Bio
A rapid diagnostic device providing antimicrobial susceptibility test results in hours, instead of days, to guide effective antibiotic treatments.
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
![Day Zero team]()
-
Evergreen Saponins
Introducing Quillaja saponaria molina as a drought-friendly crop in California and harvesting its leaves to produce QS-21, a potent vaccine adjuvant.
-
Ilios Therapeutics
Combating neurodegenerative diseases through rationally-designed multi-functional small molecules.
![Ilios team]()
-
KiraGen Bio
Harnessing the power of AI-driven combinatorial gene editing to unlock the full potential of solid tumor CAR-T therapies.
![KiraGen team]()
-
Lime Therapeutics
Creating a new class of therapies targeting lipid metabolism in cancers and neurodegenerative disorders.
-
MabLab
Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs.
![Mab Lab in their white coats at the Life Lab]()
-
Modulate Bio
Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety.
![Modulate team lead]()
-
Momentum Therapeutics
Developing therapies that restore cellular resilience by targeting the fundamental mechanisms of aging and degeneration.
![Momentum Therapeutics]()
-
Overture Therapeutics
Creating better, healthier weight-loss intervention therapies for treating obesity and its co-morbidities by targeting emerging biological pathways.
-
Revision Bio
Creating next-generation precision genome editing technologies.
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
![]()
-
TetraScience
Developing the world's only data and AI cloud built for science.
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.
